Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN2A | Q99250 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.36 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6155066 | 0.93 | SCN2A (0.45) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL8401575 | 0.81 | SIGMAR1 (0.37) | SCN2ASIGMAR1 | |
| SCHEMBL6721210 | 0.80 | SCN2A (0.42) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6155032 | 0.79 | SCN2A (0.64) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6154972 | 0.76 | EPHX1 (0.36) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL8843195 | 0.74 | KDM4E (0.40) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6156082 | 0.74 | SCN2A (0.44) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6154456 | 0.72 | SIGMAR1 (0.38) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6157307 | 0.72 | SIGMAR1 (0.38) | SCN2ASIGMAR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6155027 | 0.71 | KDM4E (0.34) | SCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0918460-A1 | METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1999-06-02 | — | — | EP | disclosed |
| WO-1998004131-A1 | METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1998-02-05 | — | — | WO | disclosed |